Literature DB >> 19885334

Plasmodium vivax malaria: status in the Republic of Korea following reemergence.

Jae-Won Park1, Gyo Jun, Joon-Sup Yeom.   

Abstract

The annual incidence of Plasmodium vivax malaria that reemerged in the Republic of Korea (ROK) in 1993 increased annually, reaching 4,142 cases in 2000, decreased to 864 cases in 2004, and once again increased to reach more than 2,000 cases by 2007. Early after reemergence, more than two-thirds of the total annual cases were reported among military personnel. However, subsequently, the proportion of civilian cases increased consistently, reaching over 60% in 2006. P. vivax malaria has mainly occurred in the areas adjacent to the Demilitarized Zone, which strongly suggests that malaria situation in ROK has been directly influenced by infected mosquitoes originating from the Democratic People's Republic of Korea (DPRK). Besides the direct influence from DPRK, local transmission within ROK was also likely. P. vivax malaria in ROK exhibited a typical unstable pattern with a unimodal peak from June through September. Chemoprophylaxis with hydroxychloroquine (HCQ) and primaquine, which was expanded from approximately 16,000 soldiers in 1997 to 200,000 soldiers in 2005, contributed to the reduction in number of cases among military personnel. However, the efficacy of the mass chemoprophylaxis has been hampered by poor compliance. Since 2000, many prophylactic failure cases due to resistance to the HCQ prophylactic regimen have been reported and 2 cases of chloroquine (CQ)-resistant P. vivax were reported, representing the first-known cases of CQ-resistant P. vivax from a temperate region of Asia. Continuous surveillance and monitoring are warranted to prevent further expansion of CQ-resistant P. vivax in ROK.

Entities:  

Keywords:  Plasmodium vivax; Republic of Korea; chemoprophylaxis; chloroquine-resistance; demilitarized zone; local transmission; malaria; reemergence; unstable malaria

Mesh:

Substances:

Year:  2009        PMID: 19885334      PMCID: PMC2769212          DOI: 10.3347/kjp.2009.47.S.S39

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  13 in total

1.  Vivax malaria: a continuing health threat to the Republic of Korea.

Authors:  Jae-Won Park; Terry A Klein; Hee-Choon Lee; Laura A Pacha; Seung-Ho Ryu; Joon-Sup Yeom; Seung-Hwan Moon; Tong-Soo Kim; Jong-Yil Chai; Myoung-Don Oh; Kang-Won Choe
Journal:  Am J Trop Med Hyg       Date:  2003-08       Impact factor: 2.345

2.  Korean vivax malaria. I. Natural history and response to chloroquine.

Authors:  D D HANKEY; R JONES; G R COATNEY; A S ALVING; W G COKER; P L GARRISON; W N DONOVAN
Journal:  Am J Trop Med Hyg       Date:  1953-11       Impact factor: 2.345

3.  Plasmodium vivax malaria in the Republic of Korea during 2004-2005: changing patterns of infection.

Authors:  Joon-Sup Yeom; Tong-Soo Kim; Sejoong Oh; Jai-Bong Sim; Jae-Sang Barn; Hye-Jung Kim; Young-A Kim; Sun-Young Ahn; Mee-Young Shin; Jie-Ae Yoo; Jae-Won Park
Journal:  Am J Trop Med Hyg       Date:  2007-05       Impact factor: 2.345

Review 4.  The economic and social burden of malaria.

Authors:  Jeffrey Sachs; Pia Malaney
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

5.  Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax.

Authors:  Hyeong-Seok Lim; Jeong-Soo Im; Joo-Youn Cho; Kyun-Seop Bae; Terry A Klein; Joon-Sup Yeom; Tae-Seon Kim; Jae-Seon Choi; In-Jin Jang; Jae-Won Park
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

6.  Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea army.

Authors:  Joon-Sup Yeom; Seung-Ho Ryu; Sejoong Oh; Dong-Hyun Choi; Kyoung-Jun Song; Young-Ha Oh; Jae-Hyun Lee; Young-A Kim; Sun-Young Ahn; Hwa-Young Yang; Je-Eun Cha; Jae-Won Park
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

7.  Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development.

Authors:  M R Galinski; J W Barnwell
Journal:  Parasitol Today       Date:  1996-01

8.  Outbreak of vivax malaria in areas adjacent to the demilitarized zone, South Korea, 1998.

Authors:  Jong Soo Lee; Won Ja Lee; Shin Hyung Cho; Han-Il Ree
Journal:  Am J Trop Med Hyg       Date:  2002-01       Impact factor: 2.345

9.  Resurgence of Plasmodium vivax malaria in the Republic of Korea during 2006-2007.

Authors:  Gyo Jun; Joon-Sup Yeom; Jee-Young Hong; E-Hyun Shin; Kyu-Sik Chang; Jae-Ran Yu; Sejoong Oh; Hyeok Chung; Jae-Won Park
Journal:  Am J Trop Med Hyg       Date:  2009-10       Impact factor: 2.345

10.  Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea.

Authors:  Kkot Sil Lee; Tae Hyong Kim; Eu Suk Kim; Hyeong-Seok Lim; Joon-Sup Yeom; Gyo Jun; Jae-Won Park
Journal:  Am J Trop Med Hyg       Date:  2009-02       Impact factor: 2.345

View more
  25 in total

1.  Geographical origin of Plasmodium vivax in the Republic of Korea: haplotype network analysis based on the parasite's mitochondrial genome.

Authors:  Moritoshi Iwagami; Seung-Young Hwang; Megumi Fukumoto; Toshiyuki Hayakawa; Kazuyuki Tanabe; So-Hee Kim; Weon-Gyu Kho; Shigeyuki Kano
Journal:  Malar J       Date:  2010-06-25       Impact factor: 2.979

Review 2.  Evidence and implications of mortality associated with acute Plasmodium vivax malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

3.  Spatial and Temporal Distribution of Plasmodium vivax Malaria in Korea Estimated with a Hierarchical Generalized Linear Model.

Authors:  Maengseok Noh; Youngjo Lee; Seungyoung Oh; Chaeshin Chu; Jin Gwack; Seung-Ki Youn; Shin Hyeong Cho; Won Ja Lee; Sun Huh
Journal:  Osong Public Health Res Perspect       Date:  2012-12

4.  Genetic polymorphism and natural selection in the C-terminal 42 kDa region of merozoite surface protein-1 among Plasmodium vivax Korean isolates.

Authors:  Jung-Mi Kang; Hye-Lim Ju; Yoo-Mi Kang; Dong-Hyun Lee; Sung-Ung Moon; Woon-Mok Sohn; Jae-Won Park; Tong-Soo Kim; Byoung-Kuk Na
Journal:  Malar J       Date:  2012-06-18       Impact factor: 2.979

5.  Plasmodium vivax populations revisited: mitochondrial genomes of temperate strains in Asia suggest ancient population expansion.

Authors:  Miao Miao; Zhaoqing Yang; Harland Patch; Yaming Huang; Ananias A Escalante; Liwang Cui
Journal:  BMC Evol Biol       Date:  2012-02-17       Impact factor: 3.260

6.  Estimated effect of climatic variables on the transmission of Plasmodium vivax malaria in the Republic of Korea.

Authors:  Young-Min Kim; Jae-Won Park; Hae-Kwan Cheong
Journal:  Environ Health Perspect       Date:  2012-06-18       Impact factor: 9.031

7.  Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial.

Authors:  Yi Poravuth; Duong Socheat; Ronnatrai Rueangweerayut; Chirapong Uthaisin; Aung Pyae Phyo; Neena Valecha; B H Krishnamoorthy Rao; Emiliana Tjitra; Asep Purnama; Isabelle Borghini-Fuhrer; Stephan Duparc; Chang-Sik Shin; Lawrence Fleckenstein
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

8.  Recent increase of genetic diversity in Plasmodium vivax population in the Republic of Korea.

Authors:  Hajime Honma; Jung-Yeon Kim; Nirianne M Q Palacpac; Toshihiro Mita; Wonja Lee; Toshihiro Horii; Kazuyuki Tanabe
Journal:  Malar J       Date:  2011-09-07       Impact factor: 2.979

9.  Population structure and transmission dynamics of Plasmodium vivax in the Republic of Korea based on microsatellite DNA analysis.

Authors:  Moritoshi Iwagami; Megumi Fukumoto; Seung-Young Hwang; So-Hee Kim; Weon-Gyu Kho; Shigeyuki Kano
Journal:  PLoS Negl Trop Dis       Date:  2012-04-03

10.  IL1B, IL4R, IL12RB1 and TNF gene polymorphisms are associated with Plasmodium vivax malaria in Brazil.

Authors:  Vinicius A Sortica; Maristela G Cunha; Maria Deise O Ohnishi; Jose M Souza; Andrea K C Ribeiro-Dos-Santos; Ney P C Santos; Sídia M Callegari-Jacques; Sidney E B Santos; Mara H Hutz
Journal:  Malar J       Date:  2012-12-07       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.